Guggenheim Raises Bristol-Myers (NYSE:BMY) Stock To a “Buy” Rating
Bristol-Myers (NYSE:BMY) Stock Upgrade Bristol-Myers (NYSE:BMY)’s stock was lifted to a solid “Buy” by analysts at Guggenheim. BMY’s past “Neutral” rating is has been discontinued…
Bristol-Myers – (NYSE:BMY)
Are Bristol-Myers (NYSE:BMY) Shares Worth Your Time and Dime Following Recent Guggenheim Upgrade?
Bristol-Myers (NYSE:BMY) Stock Upgrade In an analyst research report sent to investors and clients on Wednesday morning, investment analysts at the Guggenheim research division increased…
Bristol-Myers (NYSE:BMY) Equal Weight Rating Reemphasized Today By Barclays; The Price Target Given is $70.0
Bristol-Myers (NYSE:BMY) Rating Reaffirmed Bristol-Myers (NYSE:BMY) just had their share rating of a ‘Equal Weight’ issued by research analysts at Barclays, who now has a…
Today Barclays Maintains a “Equal Weight” Rating on Bristol-Myers (NYSE:BMY) and a $70 Target Price
Bristol-Myers (NYSE:BMY) Rating Reaffirmed In a recent research report announced this morning, Barclays kept steady their “Equal Weight” rating on Bristol-Myers (NYSE:BMY) shares. The PT…
